BRISTOL MYERS SQUIBB CO R&D Expense 2007-2025 | BMY
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is BRISTOL MYERS SQUIBB CO's current r&d expense?
BRISTOL MYERS SQUIBB CO (BMY) annual r&d expense for 2025 was $9.95B, a 10.83% decline from 2024. BRISTOL MYERS SQUIBB CO r&d expense for the quarter ending December 31, 2025 was $2.59B.
What was BRISTOL MYERS SQUIBB CO's r&d expense in 2024?
BRISTOL MYERS SQUIBB CO annual r&d expense for 2024 was $11.16B, a 20.00% increase from 2023.
What was BRISTOL MYERS SQUIBB CO's r&d expense in 2023?
BRISTOL MYERS SQUIBB CO annual r&d expense for 2023 was $9.30B, a 2.21% decline from 2022.
What is BRISTOL MYERS SQUIBB CO's 5-year r&d expense CAGR?
BRISTOL MYERS SQUIBB CO r&d expense grew at a compound annual growth rate (CAGR) of 0.19% from FY2020 to FY2025, going from $10.05B to $9.95B over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-0.2%
FY2020
$10.05B
→
FY2025
$9.95B
07080910111213141516171819202122232425
5 years selected
R&D Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $9.95B | -10.8% | 10-K |
| FY2024 | $11.16B | +20.0% | 10-K |
| FY2023 | $9.30B | -2.2% | 10-K |
| FY2022 | $9.51B | -6.7% | 10-K |
| FY2021 | $10.20B | +1.5% | 10-K |
| FY2020 | $10.05B | +63.4% | 10-K |
| FY2019 | $6.15B | -2.9% | 10-K |
| FY2018 | $6.33B | -2.1% | 10-K |
| FY2017 | $6.47B | +29.1% | 10-K |
| FY2016 | $5.01B | -15.3% | 10-K |
| FY2015 | $5.92B | +30.6% | 10-K |
| FY2014 | $4.53B | +21.5% | 10-K |
| FY2013 | $3.73B | -4.4% | 10-K |
| FY2012 | $3.90B | +1.7% | 10-K |
| FY2011 | $3.84B | +7.7% | 10-K |
| FY2010 | $3.57B | -2.2% | 10-K |
| FY2009 | $3.65B | +3.8% | 10-K |
| FY2008 | $3.51B | +11.1% | 10-K |
| FY2007 | $3.16B | - | 10-K |
Company: BRISTOL MYERS SQUIBB COTicker: BMYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →